Tag Archives: NASDAQ:PULM

Pulmatrix Inc (NASDAQ:PULM) reported earlier this month that it has picked up an additional patent related to its lead development program – PUR0200 in chronic obstructive pulmonary disease (COPD). It adds to a list of a number of already...

Pulmatrix Inc (NASDAQ:PULM) is one that we have covered on numerous occasions in the past, most recently, as part of this report back at the end of March. Year to date, the company has had a bit of a roller coaster ride. As the year began,...

We like to keep our coverage varied here at Insider Financial, but now and again, markets dictate that we revisit a company almost as soon as we’ve taken a look at it. One such situation just presented itself with development stage biotechnology...

At the beginning of February, we took a look at development stage biotech company Pulmatrix Inc (NASDAQ:PULM) as part of this piece.  At the time, the company had just run up to the tune of 130% on the back of an expedited approval process...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter